Brooks Laboratories Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Small Cap

Net Loss of Brooks Laboratories reported to Rs 9.61 crore in the quarter ended March 2024 as against net loss of Rs 4.29 crore during the previous quarter ended March 2023. Sales rose 40.52% to Rs 17.72 crore in the quarter ended March 2024 as against Rs 12.61 crore during the previous quarter ended March 2023.

For the full year,net loss reported to Rs 19.59 crore in the year ended March 2024 as against net loss of Rs 20.89 crore during the previous year ended March 2023. Sales rose 25.78% to Rs 79.49 crore in the year ended March 2024 as against Rs 63.20 crore during the previous year ended March 2023.

Powered by Capital Market - Live News

Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 18 May 2024

Powered by Capital Market - Live News

Net Loss of Brooks Laboratories reported to Rs 3.88 crore in the quarter ended December 2023 as against net loss of Rs 5.02 crore during the previous quarter ended December 2022. Sales rose 42.16% to Rs 21.75 crore in the quarter ended December 2023 as against Rs 15.30 crore during the previous quarter ended December 2022.

Powered by Capital Market - Live News

Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 31 January 2024.

Powered by Capital Market - Live News